Oxford BioMedica (GB:OXB) has released an update.
Oxford BioMedica PLC reported a change in major holdings, with Novo Holdings A/S now possessing 11.445767% of voting rights after crossing a threshold on June 19, 2024. This adjustment, notified on the same day, reflects a decrease from the previous notification’s 12.191900%. Novo Holdings A/S, under the Novo Group, holds these voting rights and is fully owned by the Novo Nordisk Foundation.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
